Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases-Reference-Cited by-同舟云学术

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

Published:2020-06-30 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Radu Letitia-Elena,Colita Andrei,Pasca Sergiu,Tomuleasa Ciprian,Popa Codruta,Serban Catalin,Gheorghe Anca,Serbanica Andreea,Jercan Cristina,Marcu Andra,Bica Ana,Teodorescu Patric,Constantinescu Catalin,Petrushev Bobe,Asan Minodora,Jardan Cerasela,Dragomir Mihaela,Tanase Alina,Colita Anca

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference19 articles.

1. Acute lymphoblastic leukemia in children;Bartram;Deutsches Aerzteblatt Online.,2012

2. Acute lymphoblastic leukaemia;Inaba;Lancet,2013

3. Declining childhood and adolescent cancer mortality: childhood and adolescent cancer mortality;Smith;Cancer,2014

4. Childhood relapsed acute lymphoblastic leukemia: biology and recent treatment progress: childhood relapsed ALL;Goto;Pediatr Int,2015

5. A single institution's experience with cytogenetic and MRD outcomes in pediatric acute lymphoblastic leukemia;Amjad;J Coll Physicians Surg Pak,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure;Cancer Genetics;2024-04

2. The Use of Flow Cytometry for MRD Detection of B- and T-ALL in Pediatric Patients;Reference Module in Biomedical Sciences;2024

3. The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia;Genes;2023-03-10

4. The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia;Journal of Clinical Medicine;2023-02-11

5. Is there a risk of early relapse in patients with acute lymphoblastic leukemia presenting with bone-associated symptoms?;Journal of Surgery and Medicine;2023-01-17